Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Task force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse | Synapse
April 23, 2026
Task force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse
Barry J. Maron
Statens Serum Institut
JI
Jeffrey M. Isner
Interventional / Structural Cardiology
William J. McKenna
Statens Serum Institut
Puntos clave
To analyze hypertrophic cardiomyopathy, myocarditis, and other myopericardial diseases alongside mitral valve prolapse.
Comprehensive literature review of current diagnostic guidelines and management protocols.
Assessment of clinical outcomes related to each condition and intervention strategies.
Expert consensus from task force members on best practices.
Identified key diagnostic criteria for hypertrophic cardiomyopathy and myocarditis with consensus endorsement.
Established management recommendations for mitral valve prolapse leading to improved patient outcomes.
Outlined the importance of interdisciplinary approaches in managing myopericardial diseases.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Maron et al. (Sat,) studied this question.
synapsesocial.com/papers/69ea8cc3afaea9b2b527002a
https://doi.org/https://doi.org/10.1016/0735-1097(94)90844-3
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir